APO Research
Talk to an analyst

APO RESEARCH · REPORT

Gastrointestinal Therapeutics and Diagnostics

Compare research editions
View pricing & licenses

Selected research

Industry Growth & Trends

Global Gastrointestinal Therapeutics and Diagnostics Industry Growth and Trends Forecast to 2032

20 December 202589 pages

Choose your research edition.

Industry ResearchGastrointestinal Therapeutics and Diagnostics Industry Research Report 2026111 pages · $2,950 USDIndustry Growth & TrendsGlobal Gastrointestinal Therapeutics and Diagnostics Industry Growth and Trends Forecast to 203289 pages · $3,450 USDMarket StructureGlobal Gastrointestinal Therapeutics and Diagnostics Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032185 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Gastrointestinal Therapeutics and Diagnostics Market Outlook and Growth Opportunities 2026197 pages · $4,250 USDMarket Analysis & ForecastGlobal Gastrointestinal Therapeutics and Diagnostics Market Analysis and Forecast 2026-2032198 pages · $4,950 USD

Market perspective

According to APO Research, the global Gastrointestinal Therapeutics and Diagnostics market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.

The North America market for Gastrointestinal Therapeutics and Diagnostics is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.

The Europe market for Gastrointestinal Therapeutics and Diagnostics is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Gastrointestinal Therapeutics and Diagnostics is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global companies in the Gastrointestinal Therapeutics and Diagnostics market include Takeda Pharmaceutical Company, Eisai, Johnson & Johnson, AstraZeneca, Salix Pharmaceuticals and Abbott Laboratories, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Scope

This report provides a structured, data-driven view of the global Gastrointestinal Therapeutics and Diagnostics market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.

The Gastrointestinal Therapeutics and Diagnostics market size, estimates, and forecasts are presented in terms of revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Gastrointestinal Therapeutics and Diagnostics market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Gastrointestinal Therapeutics and Diagnostics.

Key Companies & Market Share Insights

This section analyzes the strategies and performance of leading companies in the global Gastrointestinal Therapeutics and Diagnostics market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue and gross margin data by manufacturer for 2021-2026, enabling benchmarking of scale, profitability, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.

Gastrointestinal Therapeutics and Diagnostics Market by Company

Takeda Pharmaceutical Company

Eisai

Johnson & Johnson

AstraZeneca

Salix Pharmaceuticals

Abbott Laboratories

Gastrointestinal Therapeutics and Diagnostics Segment by Type

Diagnostics

Therapeutics

Gastrointestinal Therapeutics and Diagnostics Segment by Application

Peptic Ulcer Disease (PUD)

GI Bleeding

Gastroenteritis

Irritable Bowel Syndrome

Others

Gastrointestinal Therapeutics and Diagnostics Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Gastrointestinal Therapeutics and Diagnostics market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Gastrointestinal Therapeutics and Diagnostics and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market

5. This report helps stakeholders to gain insights into which regions to target globally

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Gastrointestinal Therapeutics and Diagnostics.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2021-2025, 2026-2031). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 3: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 4: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 5: Detailed analysis of Gastrointestinal Therapeutics and Diagnostics companies' competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.

Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.

Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, revenue by country.

Chapter 12: Concluding Insights of the report

More report detail

Tables and figures
List of Tables Table 1. Global Gastrointestinal Therapeutics and Diagnostics Market Size (US$ Million) Comparison by Region: 2021 VS 2025 VS 2032 Table 2. Global Gastrointestinal Therapeutics and Diagnostics Market Size by Region (2021-2026) & (US$ Million) Table 3. Global Gastrointestinal Therapeutics and Diagnostics Market Share by Region (2021-2026) Table 4. Global Gastrointestinal Therapeutics and Diagnostics Market Size by Region (2027-2032) & (US$ Million) Table 5. Global Gastrointestinal Therapeutics and Diagnostics Market Share by Region (2027-2032) Table 6. Global Gastrointestinal Therapeutics and Diagnostics Market Size by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 7. Global Gastrointestinal Therapeutics and Diagnostics Market Size by Type (2021-2026) & (US$ Million) Table 8. Global Gastrointestinal Therapeutics and Diagnostics Market Size Share by Type (2021-2026) Table 9. Global Gastrointestinal Therapeutics and Diagnostics Market Size Forecasted by Type (2027-2032) & (US$ Million) Table 10. Global Gastrointestinal Therapeutics and Diagnostics Market Size Share Forecasted by Type (2027-2032) Table 11. North America Gastrointestinal Therapeutics and Diagnostics Market Size Breakdown by Type (2021-2026) & (US$ Million) Table 12. North America Gastrointestinal Therapeutics and Diagnostics Market Size Breakdown by Type (2027-2032) & (US$ Million) Table 13. Europe Gastrointestinal Therapeutics and Diagnostics Market Size Breakdown by Type (2021-2026) & (US$ Million) Table 14. Europe Gastrointestinal Therapeutics and Diagnostics Market Size Breakdown by Type (2027-2032) & (US$ Million) Table 15. Asia-Pacific Gastrointestinal Therapeutics and Diagnostics Market Size Breakdown by Type (2021-2026) & (US$ Million) Table 16. Asia-Pacific Gastrointestinal Therapeutics and Diagnostics Market Size Breakdown by Type (2027-2032) & (US$ Million) Table 17. Latin America Gastrointestinal Therapeutics and Diagnostics Market Size Breakdown by Type (2021-2026) & (US$ Million) Table 18. Latin America Gastrointestinal Therapeutics and Diagnostics Market Size Breakdown by Type (2027-2032) & (US$ Million) Table 19. Middle East and Africa Gastrointestinal Therapeutics and Diagnostics Market Size Breakdown by Type (2021-2026) & (US$ Million) Table 20. Middle East and Africa Gastrointestinal Therapeutics and Diagnostics Market Size Breakdown by Type (2027-2032) & (US$ Million) Table 21. Global Gastrointestinal Therapeutics and Diagnostics Market Size by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 22. Global Gastrointestinal Therapeutics and Diagnostics Market Size by Application (2021-2026) & (US$ Million) Table 23. Global Gastrointestinal Therapeutics and Diagnostics Market Size Share by Application (2021-2026) Table 24. Global Gastrointestinal Therapeutics and Diagnostics Market Size Forecasted by Application (2027-2032) & (US$ Million) Table 25. Global Gastrointestinal Therapeutics and Diagnostics Market Size Share Forecasted by Application (2027-2032) Table 26. North America Gastrointestinal Therapeutics and Diagnostics Market Size Breakdown by Application (2021-2026) & (US$ Million) Table 27. North America Gastrointestinal Therapeutics and Diagnostics Market Size Breakdown by Application (2027-2032) & (US$ Million) Table 28. Europe Gastrointestinal Therapeutics and Diagnostics Market Size Breakdown by Application (2021-2026) & (US$ Million) Table 29. Europe Gastrointestinal Therapeutics and Diagnostics Market Size Breakdown by Application (2027-2032) & (US$ Million) Table 30. Asia-Pacific Gastrointestinal Therapeutics and Diagnostics Market Size Breakdown by Application (2021-2026) & (US$ Million) Table 31. Asia-Pacific Gastrointestinal Therapeutics and Diagnostics Market Size Breakdown by Application (2027-2032) & (US$ Million) Table 32. Latin America Gastrointestinal Therapeutics and Diagnostics Market Size Breakdown by Application (2021-2026) & (US$ Million) Table 33. Latin America Gastrointestinal Therapeutics and Diagnostics Market Size Breakdown by Application (2027-2032) & (US$ Million) Table 34. Middle East and Africa Gastrointestinal Therapeutics and Diagnostics Market Size Breakdown by Application (2021-2026) & (US$ Million) Table 35. Middle East and Africa Gastrointestinal Therapeutics and Diagnostics Market Size Breakdown by Application (2027-2032) & (US$ Million) Table 36. Gastrointestinal Therapeutics and Diagnostics Industry Trends Table 37. Gastrointestinal Therapeutics and Diagnostics Industry Drivers Table 38. Gastrointestinal Therapeutics and Diagnostics Industry Opportunities and Challenges Table 39. Gastrointestinal Therapeutics and Diagnostics Industry Restraints Table 40. Global Gastrointestinal Therapeutics and Diagnostics Revenue by Company (US$ Million) & (2021-2026) Table 41. Global Gastrointestinal Therapeutics and Diagnostics Revenue Market Share by Company (2021-2026) Table 42. Global Gastrointestinal Therapeutics and Diagnostics Industry Company Ranking, 2024 VS 2025 VS 2026 Table 43. Global Gastrointestinal Therapeutics and Diagnostics Key Company Headquarters & Area Served Table 44. Global Gastrointestinal Therapeutics and Diagnostics Company, Product Type & Application Table 45. Global Gastrointestinal Therapeutics and Diagnostics Company Commercialization Time Table 46. Global Company Market Concentration Ratio (CR5 and HHI) Table 47. Global Gastrointestinal Therapeutics and Diagnostics by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 48. Takeda Pharmaceutical Company Company Information Table 49. Takeda Pharmaceutical Company Business Overview Table 50. Takeda Pharmaceutical Company Gastrointestinal Therapeutics and Diagnostics Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 51. Takeda Pharmaceutical Company Gastrointestinal Therapeutics and Diagnostics Product Portfolio Table 52. Takeda Pharmaceutical Company Recent Development Table 53. Eisai Company Information Table 54. Eisai Business Overview Table 55. Eisai Gastrointestinal Therapeutics and Diagnostics Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 56. Eisai Gastrointestinal Therapeutics and Diagnostics Product Portfolio Table 57. Eisai Recent Development Table 58. Johnson & Johnson Company Information Table 59. Johnson & Johnson Business Overview Table 60. Johnson & Johnson Gastrointestinal Therapeutics and Diagnostics Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 61. Johnson & Johnson Gastrointestinal Therapeutics and Diagnostics Product Portfolio Table 62. Johnson & Johnson Recent Development Table 63. AstraZeneca Company Information Table 64. AstraZeneca Business Overview Table 65. AstraZeneca Gastrointestinal Therapeutics and Diagnostics Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 66. AstraZeneca Gastrointestinal Therapeutics and Diagnostics Product Portfolio Table 67. AstraZeneca Recent Development Table 68. Salix Pharmaceuticals Company Information Table 69. Salix Pharmaceuticals Business Overview Table 70. Salix Pharmaceuticals Gastrointestinal Therapeutics and Diagnostics Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 71. Salix Pharmaceuticals Gastrointestinal Therapeutics and Diagnostics Product Portfolio Table 72. Salix Pharmaceuticals Recent Development Table 73. Abbott Laboratories Company Information Table 74. Abbott Laboratories Business Overview Table 75. Abbott Laboratories Gastrointestinal Therapeutics and Diagnostics Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 76. Abbott Laboratories Gastrointestinal Therapeutics and Diagnostics Product Portfolio Table 77. Abbott Laboratories Recent Development Table 78. North America Gastrointestinal Therapeutics and Diagnostics Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 79. North America Gastrointestinal Therapeutics and Diagnostics Market Size by Country (2021-2026) & (US$ Million) Table 80. North America Gastrointestinal Therapeutics and Diagnostics Market Share by Country (2021-2026) Table 81. North America Gastrointestinal Therapeutics and Diagnostics Market Size Forecast by Country (2027-2032) & (US$ Million) Table 82. North America Gastrointestinal Therapeutics and Diagnostics Market Share Forecast by Country (2027-2032) Table 83. Europe Gastrointestinal Therapeutics and Diagnostics Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 84. Europe Gastrointestinal Therapeutics and Diagnostics Market Size by Country (2021-2026) & (US$ Million) Table 85. Europe Gastrointestinal Therapeutics and Diagnostics Market Share by Country (2021-2026) Table 86. Europe Gastrointestinal Therapeutics and Diagnostics Market Size Forecast by Country (2027-2032) & (US$ Million) Table 87. Europe Gastrointestinal Therapeutics and Diagnostics Market Share Forecast by Country (2027-2032) Table 88. Asia-Pacific Gastrointestinal Therapeutics and Diagnostics Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 89. Asia-Pacific Gastrointestinal Therapeutics and Diagnostics Market Size by Country (2021-2026) & (US$ Million) Table 90. Asia-Pacific Gastrointestinal Therapeutics and Diagnostics Market Share by Country (2021-2026) Table 91. Asia-Pacific Gastrointestinal Therapeutics and Diagnostics Market Size Forecast by Country (2027-2032) & (US$ Million) Table 92. Asia-Pacific Gastrointestinal Therapeutics and Diagnostics Market Share Forecast by Country (2027-2032) Table 93. Latin America Gastrointestinal Therapeutics and Diagnostics Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 94. Latin America Gastrointestinal Therapeutics and Diagnostics Market Size by Country (2021-2026) & (US$ Million) Table 95. Latin America Gastrointestinal Therapeutics and Diagnostics Market Share by Country (2021-2026) Table 96. Latin America Gastrointestinal Therapeutics and Diagnostics Market Size Forecast by Country (2027-2032) & (US$ Million) Table 97. Latin America Gastrointestinal Therapeutics and Diagnostics Market Share Forecast by Country (2027-2032) Table 98. Middle East & Africa Gastrointestinal Therapeutics and Diagnostics Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 99. Middle East & Africa Gastrointestinal Therapeutics and Diagnostics Market Size by Country (2021-2026) & (US$ Million) Table 100. Middle East & Africa Gastrointestinal Therapeutics and Diagnostics Market Share by Country (2021-2026) Table 101. Middle East & Africa Gastrointestinal Therapeutics and Diagnostics Market Size Forecast by Country (2027-2032) & (US$ Million) Table 102. Middle East & Africa Gastrointestinal Therapeutics and Diagnostics Market Share Forecast by Country (2027-2032) Table 103. Research Programs/Design for This Report Table 104. Authors List of This Report Table 105. Secondary Sources List of Figures Figure 1.List of Figures Figure 2. Gastrointestinal Therapeutics and Diagnostics Product Image Figure 3. Global Gastrointestinal Therapeutics and Diagnostics Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 4. Global Gastrointestinal Therapeutics and Diagnostics Market Size (2021-2032) & (US$ Million) Figure 5. Global Gastrointestinal Therapeutics and Diagnostics Market Share by Region: 2025 VS 2032 Figure 6. Global Gastrointestinal Therapeutics and Diagnostics Market Share by Region (2021-2032) Figure 7. North America Gastrointestinal Therapeutics and Diagnostics Market Size Growth Rate (2021-2032) & (US$ Million) Figure 8. Europe Gastrointestinal Therapeutics and Diagnostics Market Size Growth Rate (2021-2032) & (US$ Million) Figure 9. Asia-Pacific Gastrointestinal Therapeutics and Diagnostics Market Size Growth Rate (2021-2032) & (US$ Million) Figure 10. Latin America Gastrointestinal Therapeutics and Diagnostics Market Size Growth Rate (2021-2032) & (US$ Million) Figure 11. Middle East & Africa Gastrointestinal Therapeutics and Diagnostics Market Size Growth Rate (2021-2032) & (US$ Million) Figure 12. Diagnostics Image Figure 13. Global Diagnostics Market Size YoY Growth (2021-2032) & (US$ Million) Figure 14. Therapeutics Image Figure 15. Global Therapeutics Market Size YoY Growth (2021-2032) & (US$ Million) Figure 16. Global Gastrointestinal Therapeutics and Diagnostics Market Size Overview by Type (2021-2032) & (US$ Million) Figure 17. Global Gastrointestinal Therapeutics and Diagnostics Market Share by Type 2025 VS 2032 Figure 18. North America Gastrointestinal Therapeutics and Diagnostics Market Size Share by Type (2021-2032) Figure 19. Europe Gastrointestinal Therapeutics and Diagnostics Market Size Share by Type (2021-2032) Figure 20. Asia-Pacific Gastrointestinal Therapeutics and Diagnostics Market Size Share by Type (2021-2032) Figure 21. Latin America Gastrointestinal Therapeutics and Diagnostics Market Size Share by Type (2021-2032) Figure 22. Middle East and Africa Gastrointestinal Therapeutics and Diagnostics Market Size Share by Type (2021-2032) Figure 23. Peptic Ulcer Disease (PUD) Image Figure 24. Global Peptic Ulcer Disease (PUD) Market Size YoY Growth (2021-2032) & (US$ Million) Figure 25. GI Bleeding Image Figure 26. Global GI Bleeding Market Size YoY Growth (2021-2032) & (US$ Million) Figure 27. Gastroenteritis Image Figure 28. Global Gastroenteritis Market Size YoY Growth (2021-2032) & (US$ Million) Figure 29. Irritable Bowel Syndrome Image Figure 30. Global Irritable Bowel Syndrome Market Size YoY Growth (2021-2032) & (US$ Million) Figure 31. Others Image Figure 32. Global Others Market Size YoY Growth (2021-2032) & (US$ Million) Figure 33. Global Gastrointestinal Therapeutics and Diagnostics Market Size Overview by Application (2021-2032) & (US$ Million) Figure 34. Global Gastrointestinal Therapeutics and Diagnostics Market Share by Application 2025 VS 2032 Figure 35. North America Gastrointestinal Therapeutics and Diagnostics Market Size Share by Application (2021-2032) Figure 36. Europe Gastrointestinal Therapeutics and Diagnostics Market Size Share by Application (2021-2032) Figure 37. Asia-Pacific Gastrointestinal Therapeutics and Diagnostics Market Size Share by Application (2021-2032) Figure 38. Latin America Gastrointestinal Therapeutics and Diagnostics Market Size Share by Application (2021-2032) Figure 39. Middle East and Africa Gastrointestinal Therapeutics and Diagnostics Market Size Share by Application (2021-2032) Figure 40. Global Top 5 and 10 Gastrointestinal Therapeutics and Diagnostics Players Market Share by Revenue in 2025 Figure 41. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 42. North America Gastrointestinal Therapeutics and Diagnostics Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 43. North America Gastrointestinal Therapeutics and Diagnostics Market Share by Country: 2021 VS 2025 VS 2032 Figure 44. North America Gastrointestinal Therapeutics and Diagnostics Market Share by Country (2021-2032) Figure 45. Europe Gastrointestinal Therapeutics and Diagnostics Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 46. Europe Gastrointestinal Therapeutics and Diagnostics Market Share by Country: 2021 VS 2025 VS 2032 Figure 47. Europe Gastrointestinal Therapeutics and Diagnostics Market Share by Country (2021-2032) Figure 48. Asia-Pacific Gastrointestinal Therapeutics and Diagnostics Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 49. Asia-Pacific Gastrointestinal Therapeutics and Diagnostics Market Share by Country: 2021 VS 2025 VS 2032 Figure 50. Asia-Pacific Gastrointestinal Therapeutics and Diagnostics Market Share by Country (2021-2032) Figure 51. Latin America Gastrointestinal Therapeutics and Diagnostics Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 52. Latin America Gastrointestinal Therapeutics and Diagnostics Market Share by Country: 2021 VS 2025 VS 2032 Figure 53. Latin America Gastrointestinal Therapeutics and Diagnostics Market Share by Country (2021-2032) Figure 54. Middle East & Africa Gastrointestinal Therapeutics and Diagnostics Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 55. Middle East & Africa Gastrointestinal Therapeutics and Diagnostics Market Share by Country: 2021 VS 2025 VS 2032 Figure 56. Middle East & Africa Gastrointestinal Therapeutics and Diagnostics Market Share by Country (2021-2032) Figure 57. Years Considered Figure 58. Research Process Figure 59. Key Executives Interviewed

Scope & coverage.

Types
  • Diagnostics
  • Therapeutics
Applications
  • Peptic Ulcer Disease (PUD)
  • GI Bleeding
  • Gastroenteritis
  • Irritable Bowel Syndrome
  • Others
Companies covered
  • Takeda Pharmaceutical Company
  • Eisai
  • Johnson & Johnson
  • AstraZeneca
  • Salix Pharmaceuticals
  • Abbott Laboratories

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.3 Global Gastrointestinal Therapeutics and Diagnostics Market Size Overview by Region 2021 VS 2025 VS 2032
  4. 1.4 Global Gastrointestinal Therapeutics and Diagnostics Market Size by Region (2021-2032)
  5. 1.4.1 Global Gastrointestinal Therapeutics and Diagnostics Market Size by Region (2021-2026)
  6. 1.4.2 Global Gastrointestinal Therapeutics and Diagnostics Market Size by Region (2027-2032)
  7. 1.5 Key Regions Gastrointestinal Therapeutics and Diagnostics Market Size (2021-2032)
  8. 1.5.1 North America Gastrointestinal Therapeutics and Diagnostics Market Size Growth Rate (2021-2032)
  9. 1.5.2 Europe Gastrointestinal Therapeutics and Diagnostics Market Size Growth Rate (2021-2032)
  10. 1.5.3 Asia-Pacific Gastrointestinal Therapeutics and Diagnostics Market Size Growth Rate (2021-2032)
  11. 1.5.4 South America Gastrointestinal Therapeutics and Diagnostics Market Size Growth Rate (2021-2032)
  12. 1.5.5 Middle East & Africa Gastrointestinal Therapeutics and Diagnostics Market Size Growth Rate (2021-2032)
2 Gastrointestinal Therapeutics and Diagnostics Market by Type
  1. 2.1 Type Introduction
  2. 2.1.1 Diagnostics
  3. 2.1.2 Therapeutics
  4. 2.2 Global Gastrointestinal Therapeutics and Diagnostics Market Size by Type
  5. 2.2.1 Global Gastrointestinal Therapeutics and Diagnostics Market Size Overview by Type (2021-2032)
  6. 2.2.2 Global Gastrointestinal Therapeutics and Diagnostics Historic Market Size Review by Type (2021-2026)
  7. 2.2.3 Global Gastrointestinal Therapeutics and Diagnostics Market Size Forecasted by Type (2027-2032)
  8. 2.3 Global Gastrointestinal Therapeutics and Diagnostics Market Size by Regions
  9. 2.3.1 North America Gastrointestinal Therapeutics and Diagnostics Market Size Breakdown by Type (2021-2026)
  10. 2.3.2 Europe Gastrointestinal Therapeutics and Diagnostics Market Size Breakdown by Type (2021-2026)
  11. 2.3.3 Asia-Pacific Gastrointestinal Therapeutics and Diagnostics Market Size Breakdown by Type (2021-2026)
  12. 2.3.4 South America Gastrointestinal Therapeutics and Diagnostics Market Size Breakdown by Type (2021-2026)
  13. 2.3.5 Middle East and Africa Gastrointestinal Therapeutics and Diagnostics Market Size Breakdown by Type (2021-2026)
3 Gastrointestinal Therapeutics and Diagnostics Market by Application
  1. 3.1 Type Introduction
  2. 3.1.1 Peptic Ulcer Disease (PUD)
  3. 3.1.2 GI Bleeding
  4. 3.1.3 Gastroenteritis
  5. 3.1.4 Irritable Bowel Syndrome
  6. 3.1.5 Others
  7. 3.2 Global Gastrointestinal Therapeutics and Diagnostics Market Size by Application
  8. 3.2.1 Global Gastrointestinal Therapeutics and Diagnostics Market Size Overview by Application (2021-2032)
  9. 3.2.2 Global Gastrointestinal Therapeutics and Diagnostics Historic Market Size Review by Application (2021-2026)
  10. 3.2.3 Global Gastrointestinal Therapeutics and Diagnostics Market Size Forecasted by Application (2027-2032)
  11. 3.3 Global Gastrointestinal Therapeutics and Diagnostics Market Size by Regions
  12. 3.3.1 North America Gastrointestinal Therapeutics and Diagnostics Market Size Breakdown by Application (2021-2026)
  13. 3.3.2 Europe Gastrointestinal Therapeutics and Diagnostics Market Size Breakdown by Application (2021-2026)
  14. 3.3.3 Asia-Pacific Gastrointestinal Therapeutics and Diagnostics Market Size Breakdown by Application (2021-2026)
  15. 3.3.4 South America Gastrointestinal Therapeutics and Diagnostics Market Size Breakdown by Application (2021-2026)
  16. 3.3.5 Middle East and Africa Gastrointestinal Therapeutics and Diagnostics Market Size Breakdown by Application (2021-2026)
4 Global Market Dynamics
  1. 4.1 Gastrointestinal Therapeutics and Diagnostics Industry Trends
  2. 4.2 Gastrointestinal Therapeutics and Diagnostics Industry Drivers
  3. 4.3 Gastrointestinal Therapeutics and Diagnostics Industry Opportunities and Challenges
  4. 4.4 Gastrointestinal Therapeutics and Diagnostics Industry Restraints
5 Competitive Insights by Company
  1. 5.1 Global Top Players by Gastrointestinal Therapeutics and Diagnostics Revenue (2021-2026)
  2. 5.2 Global Gastrointestinal Therapeutics and Diagnostics Industry Company Ranking, 2024 VS 2025 VS 2026
  3. 5.3 Global Gastrointestinal Therapeutics and Diagnostics Key Company Headquarters & Area Served
  4. 5.4 Global Gastrointestinal Therapeutics and Diagnostics Company, Product Type & Application
  5. 5.5 Global Gastrointestinal Therapeutics and Diagnostics Company Commercialization Time
  6. 5.6 Market Competitive Analysis
  7. 5.6.1 Global Gastrointestinal Therapeutics and Diagnostics Market CR5 and HHI
  8. 5.6.2 Global Top 5 and 10 Gastrointestinal Therapeutics and Diagnostics Players Market Share by Revenue in 2025
  9. 5.6.3 2025 Gastrointestinal Therapeutics and Diagnostics Tier 1, Tier 2, and Tier 3
6 Company Profiles
  1. 6.1 Takeda Pharmaceutical Company
  2. 6.1.1 Takeda Pharmaceutical Company Company Information
  3. 6.1.2 Takeda Pharmaceutical Company Business Overview
  4. 6.1.3 Takeda Pharmaceutical Company Gastrointestinal Therapeutics and Diagnostics Revenue, Global Share and Gross Margin (2021-2026)
  5. 6.1.4 Takeda Pharmaceutical Company Gastrointestinal Therapeutics and Diagnostics Product Portfolio
  6. 6.1.5 Takeda Pharmaceutical Company Recent Developments
  7. 6.2 Eisai
  8. 6.2.1 Eisai Company Information
  9. 6.2.2 Eisai Business Overview
  10. 6.2.3 Eisai Gastrointestinal Therapeutics and Diagnostics Revenue, Global Share and Gross Margin (2021-2026)
  11. 6.2.4 Eisai Gastrointestinal Therapeutics and Diagnostics Product Portfolio
  12. 6.2.5 Eisai Recent Developments
  13. 6.3 Johnson & Johnson
  14. 6.3.1 Johnson & Johnson Company Information
  15. 6.3.2 Johnson & Johnson Business Overview
  16. 6.3.3 Johnson & Johnson Gastrointestinal Therapeutics and Diagnostics Revenue, Global Share and Gross Margin (2021-2026)
  17. 6.3.4 Johnson & Johnson Gastrointestinal Therapeutics and Diagnostics Product Portfolio
  18. 6.3.5 Johnson & Johnson Recent Developments
  19. 6.4 AstraZeneca
  20. 6.4.1 AstraZeneca Company Information
  21. 6.4.2 AstraZeneca Business Overview
  22. 6.4.3 AstraZeneca Gastrointestinal Therapeutics and Diagnostics Revenue, Global Share and Gross Margin (2021-2026)
  23. 6.4.4 AstraZeneca Gastrointestinal Therapeutics and Diagnostics Product Portfolio
  24. 6.4.5 AstraZeneca Recent Developments
  25. 6.5 Salix Pharmaceuticals
  26. 6.5.1 Salix Pharmaceuticals Company Information
  27. 6.5.2 Salix Pharmaceuticals Business Overview
  28. 6.5.3 Salix Pharmaceuticals Gastrointestinal Therapeutics and Diagnostics Revenue, Global Share and Gross Margin (2021-2026)
  29. 6.5.4 Salix Pharmaceuticals Gastrointestinal Therapeutics and Diagnostics Product Portfolio
  30. 6.5.5 Salix Pharmaceuticals Recent Developments
  31. 6.6 Abbott Laboratories
  32. 6.6.1 Abbott Laboratories Company Information
  33. 6.6.2 Abbott Laboratories Business Overview
  34. 6.6.3 Abbott Laboratories Gastrointestinal Therapeutics and Diagnostics Revenue, Global Share and Gross Margin (2021-2026)
  35. 6.6.4 Abbott Laboratories Gastrointestinal Therapeutics and Diagnostics Product Portfolio
  36. 6.6.5 Abbott Laboratories Recent Developments
7 North America
  1. 7.1 North America Gastrointestinal Therapeutics and Diagnostics Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  2. 7.2 North America Gastrointestinal Therapeutics and Diagnostics Market Size by Country (2021-2026)
  3. 7.3 North America Gastrointestinal Therapeutics and Diagnostics Market Size Forecast by Country (2027-2032)
8 Europe
  1. 8.1 Europe Gastrointestinal Therapeutics and Diagnostics Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  2. 8.2 Europe Gastrointestinal Therapeutics and Diagnostics Market Size by Country (2021-2026)
  3. 8.3 Europe Gastrointestinal Therapeutics and Diagnostics Market Size Forecast by Country (2027-2032)
9 Asia-Pacific
  1. 9.1 Asia-Pacific Gastrointestinal Therapeutics and Diagnostics Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  2. 9.2 Asia-Pacific Gastrointestinal Therapeutics and Diagnostics Market Size by Country (2021-2026)
  3. 9.3 Asia-Pacific Gastrointestinal Therapeutics and Diagnostics Market Size Forecast by Country (2027-2032)
10 South America
  1. 10.1 South America Gastrointestinal Therapeutics and Diagnostics Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  2. 10.2 South America Gastrointestinal Therapeutics and Diagnostics Market Size by Country (2021-2026)
  3. 10.3 South America Gastrointestinal Therapeutics and Diagnostics Market Size Forecast by Country (2027-2032)
11 Middle East & Africa
  1. 11.1 Middle East & Africa Gastrointestinal Therapeutics and Diagnostics Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  2. 11.2 Middle East & Africa Gastrointestinal Therapeutics and Diagnostics Market Size by Country (2021-2026)
  3. 11.3 Middle East & Africa Gastrointestinal Therapeutics and Diagnostics Market Size Forecast by Country (2027-2032)
12 Concluding Insights
    13 Appendix
    1. 13.1 Reasons for Doing This Study
    2. 13.2 Research Methodology
    3. 13.3 Research Process
    4. 13.4 Authors List of This Report
    5. 13.5 Data Source
    6. 13.5.1 Secondary Sources
    7. 13.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,450USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst